Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Recursion Pharmaceuticals, Inc. - Class A Common Stock (NQ:RXRX)

4.178 +0.038 (+0.91%)
Streaming Delayed Price Updated: 11:34 AM EST, Nov 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Recursion Pharmaceuticals, Inc. - Class A Common Stock

< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
News headline image
Cathie Wood's Ark Invest Buys $16M Worth Of Shares Of Flying Taxi Company Archer Aviation — Sells Shopify Stock Worth Millions ↗
 
Via Benzinga
News headline image
These 9 AI Stocks Are Up 95%, On Average, Since End Of April ↗
Nine artificial intelligence and AI-related stocks, with market caps in excess of $2B, have advanced by +60% since the bubble began to develop at the end of April into early May, with an average... 
Via Talk Markets
Topics Artificial Intelligence
News headline image
Every AI Stock Cathie Wood Owns, Ranked From Best to Worst ↗
You can find some great AI investment opportunities by looking at the stocks in Wood's Ark Invest portfolio. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
3 Things About Recursion Pharmaceuticals That Smart Investors Know ↗
Until it can get some recurring revenue going, it'll be a risky stock to buy. 
Via The Motley Fool
News headline image
Analyst Expectations for Recursion Pharmaceuticals's Future ↗
 
Via Benzinga
News headline image
3 AI Stocks You’ll Regret Not Buying Soon ↗
AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in. 
Via InvestorPlace
News headline image
Recursion Bridges the Protein and Chemical Space with Massive Protein-Ligand Interaction Predictions Spanning 36 Billion Compounds
Recursion has predicted the protein target(s) for approximately 36 billion chemical compounds in the Enamine REAL Space, reported to be the world’s largest searchable chemical library. These advances... 
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Recursion Provides Business Updates and Reports Second Quarter 2023 Financial Results
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Cathie Wood Buys Shares Of Pacific Biosciences, Reduces Exposure To DraftKings And Genius Sports ↗
 
Via Benzinga
News headline image
2 Healthcare AI Stocks That Could Go Parabolic ↗
Shares of Recursion Pharmaceuticals and GE Healthcare are both up sharply so far this year. 
Via The Motley Fool
News headline image
Recursion to Participate in Upcoming Investor Conference
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
Here are 3 AI Drug Discovery Stocks to Put on Your Watchlist
Artificial intelligence (AI) has hit the mainstream with fervor. Specifically, generative AI has gone viral with the explosion in ChatGPT users. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
These 10 AI Stocks Are Up An Average Of 99% In Last 3 Months ↗
Ten artificial intelligence and AI-related (AI&R) stocks, with market capitalizations of +$1.5B, have advanced by 70% or more (average of 99%!) since the bubble began to develop at the end of April.... 
Via Talk Markets
News headline image
10 Health Care Stocks With Whale Alerts In Today's Session ↗
 
Via Benzinga
News headline image
Biotech & Healthcare Meet AI: Stocks Soar On Innovation Potential
A growing number of companies in the biotech and healthcare industries are using AI to revolutionize drug discovery and patient care, leading to stock surges. 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Exscientia is the Sniper of the AI Drug Discovery Industry
News of a $50 million investment by artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA) into AI-powered drug discovery company Recursion 
Via MarketBeat
Topics Artificial Intelligence
News headline image
Nvidia’s AI Explosion: What NVDA Stock Investors Need to Know Now ↗
Rather than sell your Nvidia shares, diversify. That's what the Cloud Czars want to do. They'll save, and you'll profit. 
Via InvestorPlace
News headline image
Recursion Launches Valence Labs at ICML with a Commitment to Open Science Including $1 Million in Academic Scholarships
Valence Labs is Recursion’s new machine learning research center that aims to promote open science and academic research. $1 million will be committed to advancing the next generation of academic... 
From Recursion Pharmaceuticals
Via GlobeNewswire
News headline image
These 26 AI Stocks Are Up 58% In Just 11 Weeks ↗
The Bank of America suggests that this is just a 
Via Talk Markets
News headline image
MarketBeat Week in Review – 7/17 - 7/21
Investor sentiment remains strong but upcoming tech earnings and an expected interest rate hike may provide more clarity on the short-term outlook for stocks 
Via MarketBeat
Topics Economy
News headline image
3 Cutting-Edge Biotech Stocks That Are Riding the AI Wave Like None Other ↗
They're not guaranteed to keep soaring, but they are right now. 
Via The Motley Fool
News headline image
Did Nvidia Just Trigger a Short Squeeze in RXRX Stock? ↗
Recursion Pharmaceuticals continues to rally higher, with RXRX stock now up more than 100% after Nvidia invested in the firm last week. 
Via InvestorPlace
News headline image
AT&T, Carvana, Northern Trust, And Other Big Stocks Moving Higher On Wednesday ↗
U.S. stocks traded higher, with the Dow Jones gaining over 250 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why It May Not Be Too Late to Join Nvidia’s Sky-High AI Rally ↗
As long as Nvidia is a darling of the market - and as long as the company invests in future-facing technology - NVDA stock has room to run. 
Via InvestorPlace
News headline image
Better AI Biotech Stock: Schrödinger vs. Recursion Pharmaceuticals ↗
Both companies could tap into huge growth from the AI revolution in a few years. 
Via The Motley Fool
News headline image
NVIDIA Just Invested $50 Million in This Biotech -- Should You Buy It? ↗
Gaining one of the world's most important AI companies as a collaborator is huge. 
Via The Motley Fool
News headline image
NVDA Stock Update: What Nvidia Investors Need to Be Watching Now ↗
With Nvidia still the best option for long-term investors looking to take advantage of the AI race, here's what to watch. 
Via InvestorPlace
News headline image
Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks ↗
Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%. 
Via Talk Markets
News headline image
Nvidia Invested $50 million into This AI Drug Discovery Biotech
Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from 
Via MarketBeat
Topics Artificial Intelligence
News headline image
3 Biotech Stocks Using AI to Change Healthcare Forever ↗
These three biotech firms are leveraging artificial intelligence to revolutionize therapeutics and make disease a thing of the past. 
Via InvestorPlace
< Previous 1 2
...
14 15 16 17 18 19 20 21 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.